Spontaneous Atrial Fibrillation in Transgenic Goats With TGF (Transforming Growth Factor)-β1 Induced Atrial Myopathy With Endurance Exercise

被引:16
|
作者
Regouski, Misha [1 ]
Galenko, Oxana [2 ]
Doleac, Jason [4 ]
Olsen, Aaron L. [1 ]
Jacobs, Victoria [2 ]
Liechty, Dustin [5 ]
White, Kenneth L. [1 ]
Bunch, T. Jared [1 ,2 ,3 ]
Lee, Pamela M. [5 ]
Rutigliano, Heloisa M. [1 ]
Polejaeva, Irina A. [1 ]
Cutler, Michael J. [1 ,2 ]
机构
[1] Utah State Univ, Dept Anim Dairy & Vet Sci, 4815 Old Main Hill, Logan, UT 84322 USA
[2] Intermt Med Ctr, Intermt Med Ctr Heart Inst, Murray, KY 84107 USA
[3] Stanford Univ, Dept Internal Med, Palo Alto, CA 94304 USA
[4] Boston Sci Inc, Minneapolis, MN USA
[5] Washington State Univ, Coll Vet Med, Pullman, WA 99164 USA
来源
关键词
atrial fibrillation; biomarker; goats; microRNA; transforming growth factor; MICRORNAS; FIBROSIS; OVEREXPRESSION; INFLAMMATION; MECHANISMS; DISEASE; MARKERS; PLASMA; MODEL;
D O I
10.1161/CIRCEP.119.007499
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is increasing evidence that endurance exercise is associated with increased risk of atrial fibrillation (AF). However, it is unknown if the relationship between endurance exercise and AF is dependent on an atrial myopathy. Methods: Six cardiac-specific TGF (transforming growth factor)-beta 1 transgenic and 6 wild-type (WT) goats were utilized for these studies. Pacemakers were implanted in all animals for continuous arrhythmia monitoring and AF inducibility. AF inducibility was evaluated using 5 separate 10 s bursts of atrial pacing (160-200 ms). Three months of progressive endurance exercise (up to 90 minutes at 4.5 mph) was performed. Quantitative assessment of circulating microRNAs and inflammatory biomarkers was performed. Results: Sustained AF (>= 30 s) was induced with 10 s of atrial pacing in 4 out of 6 transgenic goats compared with 0 out of 6 WT controls at baseline (P<0.05). No spontaneous AF was observed at baseline. Interestingly, between 2 and 3 months of exercise 3 out of 6 transgenic animals developed self-terminating spontaneous AF compared with 0 out of 6 WT animals (P<0.05). There was an increase in AF inducibility in both transgenic and WT animals during the first 2 months of exercise with partial normalization at 3 months (transgenic 67%; 100%; 83% versus WT 0%; 67%; 17%). These changes in AF susceptibility were associated with a decrease in circulating microRNA-21 and microRNA-29 during the first 2 months of exercise with partial normalization at 3 months in both transgenic and WT animals. Finally, MMP9 (matrix metallopeptidase 9) was increased during the second and third months of exercise training. Conclusions: This study demonstrates a novel transgenic goat model of cardiac fibrosis (TGF-beta 1 overexpression) to demonstrate that endurance exercise in the setting of an underlying atrial myopathy increases the incidence of spontaneous AF. Furthermore, endurance exercise seems to increase inducible AF secondary to altered expression of key profibrotic biomarkers that is independent of the presence of an atrial myopathy.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway
    Wu, Yingbiao
    Can, Jin
    Hao, Shuwen
    Qiang, Xun
    Ning, Zhongping
    CEREBROVASCULAR DISEASES, 2022, 51 (02) : 188 - 198
  • [42] Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-1
    Rahmutula, Dolkun
    Marcus, Gregory M.
    Wilson, Emily E.
    Ding, Chun-Hua
    Xiao, Yuanyuan
    Paquet, Agnes C.
    Barbeau, Rebecca
    Barczak, Andrea J.
    Erle, David J.
    Olgin, Jeffrey E.
    CARDIOVASCULAR RESEARCH, 2013, 99 (04) : 769 - 779
  • [43] Transforming growth factor β1-mediated atrial fibrotic activity and the recovery of atrial mechanical contraction after surgical maze procedure
    Park, Seung-Jung
    On, Young Keun
    Kim, June Soo
    Choi, Jin-Oh
    Ju, Eun-Seon
    Jeong, Dong Seop
    Park, Pyo Won
    Jeon, Eun-Seok
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 164 (02) : 232 - 237
  • [44] Atrial natriuretic peptide (ANP) inhibits transforming growth factor (TGF)-β1-induced nuclear translocation of Smad3 and myofibroblast transformation in mouse cardiac fibroblasts
    Wang, DJ
    Oparil, S
    Xing, DQ
    Shi, WB
    Cao, X
    Chen, YF
    CIRCULATION, 2005, 112 (17) : U154 - U154
  • [45] Induction of corneal myofibroblasts by lens-derived transforming growth factor β1 (TGFβ1): A transgenic mouse model
    Reneker, Lixing W.
    Bloch, Amy
    Xie, Leike
    Overbeek, Paul A.
    Ash, John D.
    BRAIN RESEARCH BULLETIN, 2010, 81 (2-3) : 287 - 296
  • [46] Renal, transgenic overexpression of transforming growth factor-β1 (TGF-β1) induces functional changes in the kidney
    Krag, SR
    Hermans, C
    Bach, L
    Aarhus, C
    DIABETES, 1999, 48 : A142 - A142
  • [47] The eyes of transforming growth factor-beta 1 (TGF-beta 1) transgenic mice - Morphology and the development of endotoxin-induced uveitis
    Chan, CC
    Factor, V
    Li, Q
    Nagy, P
    Peng, B
    Thorgeirsson, SS
    OCULAR IMMUNOLOGY AND INFLAMMATION, 1996, 4 (04) : 183 - 191
  • [48] Transforming growth factor-β1 (TGF-β1)-induced myocardial fibrosis is associated with an inhibition of interstitial collagenase (MMP) activity in transgenic mice
    Seeland, U
    Haeuseler, C
    Hinrichs, R
    Pfitzner, T
    Scharffetter-Kochanek, K
    CIRCULATION, 2001, 104 (17) : 187 - 187
  • [49] Apelin Inhibits Angiotensin II-Induced Atrial Fibrosis and Atrial Fibrillation via TGF-β1/Smad2/α-SMA Pathway
    Lv, Wenkui
    Zhang, Ling
    Cheng, Xinchun
    Wang, Hongli
    Qin, Wen
    Zhou, Xianhui
    Tang, Baopeng
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [50] Acceleration of c-myc-induced hepatocarcinogenesis by co-expression of transforming growth factor (TGF)-α in transgenic mice is associated with TGF-β1 signaling disruption
    Santoni-Rugiu, E
    Jensen, MR
    Factor, VM
    Thorgeirsson, SS
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (06): : 1693 - 1700